To validate the three targets, we performed correlation analysis using PC samples in The Cancer Genome Atlas (TCGA) database and found only C-FOS was significantly correlated with both RUNX1-IT1 and RUNX1 in the clinical specimens (Additional file 12: Supplementary Fig. S6a–c). Here, RUNX1 is linked to pachyonychia congenita.